Bluejay Diagnostics (BJDX) Accumulated Expenses (2020 - 2025)

Bluejay Diagnostics has disclosed Accumulated Expenses across 6 years of filings, most recently posting $804942.0 for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $804942.0, up 45.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $804942.0 (up 45.83% YoY), and the FY2025 annual result was $804942.0, up 45.83% from the prior year.
• Accumulated Expenses came in at $804942.0 for Q4 2025 at Bluejay Diagnostics, up from $74400.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.4 million in Q2 2023 to a low of $74400.0 in Q3 2025.
• The 5-year median for Accumulated Expenses is $592622.0 (2022), against an average of $646019.1.
• Across the five-year window, Accumulated Expenses soared 190.79% in 2022 and slumped 83.68% in 2025, its largest moves.
• Bluejay Diagnostics' Accumulated Expenses stood at $341384.0 in 2021, then surged by 144.81% to $835730.0 in 2022, then jumped by 33.64% to $1.1 million in 2023, then sank by 50.58% to $551986.0 in 2024, then soared by 45.83% to $804942.0 in 2025.
• The last three Accumulated Expenses figures came in at $804942.0 (Q4 2025), $74400.0 (Q3 2025), and $164631.0 (Q2 2025), per Business Quant data.